KEARNY, N.J.--(BUSINESS WIRE)--Pharmachem Innovations, LLC (“Pharmachem” or the “Company”), a leading provider of nutraceuticals products and solutions, today announced its launch as an independent company, following the acquisition of the Company from Ashland, Inc. (NYSE: ASH) by Turnspire Capital Partners LLC (“Turnspire”)..

新泽西州卡尼——（商业新闻短讯）——Pharmachem Innovations，LLC（“Pharmachem”或“本公司”）是一家领先的营养保健产品和解决方案提供商，继Turnspire Capital Partners LLC（“Turnspire”）从Ashland，Inc.（纽约证券交易所：ASH）收购该公司后，该公司今天宣布成立为一家独立公司。。

Headquartered in Kearny, NJ, Pharmachem has a long history of working closely with customers around the world to develop and produce a wide range of specialized nutraceuticals. From its manufacturing facilities in New Jersey and Utah in the United States and Tamaulipas, Mexico, Pharmachem produces a wide range of proprietary and private labeled products used in many applications, including hydration, joint health, women’s and men’s health, and cardiovascular health.

Pharmachem总部位于新泽西州科尔尼，拥有与世界各地客户密切合作开发和生产各种专业营养保健品的悠久历史。Pharmachem在美国新泽西州和犹他州以及墨西哥塔毛利帕斯的制造工厂生产各种专有和私人标签产品，用于许多应用，包括水合作用，关节健康，女性和男性健康以及心血管健康。

The Company also provides custom formulation and contract manufacturing services to the nutrition market, handling everything from formula design and ingredient sourcing to finished product manufacturing..

该公司还为营养市场提供定制配方和合同制造服务，从配方设计和配料采购到成品制造。。

Pharmachem announced that Maurice Murphy, an Operating Partner with Turnspire, has been named Executive Chairman of the Board. Mr. Murphy was most recently CEO of UPG, a former Turnspire portfolio company, where he led the company’s transformation into a customer-focused industry leader.

Pharmachem宣布，Turnspire的运营合作伙伴莫里斯·墨菲（MauriceMurphy）已被任命为董事会执行主席。墨菲先生最近担任了UPG的首席执行官，UPG是一家前Turnspire投资组合公司，他领导该公司转型为以客户为中心的行业领导者。

“I am thrilled to join a company as customer-centric and innovation-driven as Pharmachem,” said Mr. Murphy. “As an independent company with Turnspire’s support, we will be able to accelerate the Company’s growth through close partnerships with high-caliber customers and investments in new capabilities.”.

墨菲先生说：“我很高兴加入一家像Pharmachem这样以客户为中心、以创新为驱动的公司。”。“作为一家在Turnspire支持下的独立公司，我们将能够通过与高素质客户的密切合作以及对新功能的投资来加速公司的增长。”。

Pharmachem also announced the appointment of Jeff Rogers, a seasoned executive in the ingredients space, as Interim Chief Executive Officer. Mr. Rogers was most recently President and Chief Operating Officer of Niacet, where he was responsible for leading the company’s commercial and manufacturing operations.

Pharmachem还宣布任命配料领域经验丰富的高管杰夫·罗杰斯（JeffRogers）为临时首席执行官。罗杰斯先生最近担任Niacet总裁兼首席运营官，负责领导公司的商业和制造业务。

He has also held leadership roles at Ashland, Lonza, AkzoNobel, and National Starch..

他还曾在Ashland、Lonza、阿克苏诺贝尔和National Starch担任领导职务。。

“I am excited to join the Pharmachem team and build on its rich legacy as an innovator in the nutraceuticals space,” said Mr. Rogers. “We look forward to partnering with our valued customers to develop new and creative custom formulations and proprietary products. We are excited to leverage our vast capabilities to pursue a wide array of attractive growth opportunities while continuing to provide the highest-quality service for our customers.”.

罗杰斯先生说：“我很高兴加入Pharmachem团队，并在其丰富的营养保健领域的创新者遗产的基础上再接再厉。”。“我们期待着与我们的尊贵客户合作，开发新的创造性定制配方和专有产品。我们很高兴利用我们的巨大能力，寻求各种有吸引力的增长机会，同时继续为我们的客户提供最高质量的服务。”。

In addition to Mr. Murphy and Mr. Rogers, Pharmachem will be led by members of its current management team.

除墨菲先生和罗杰斯先生外，Pharmachem将由其现有管理团队的成员领导。

Pharmachem was the original name of the Company and was used from its founding in 1972 until 2017. As Pharmachem becomes an independent company again, the team is excited to leverage its legacy name while adding “Innovations” to reflect its path forward as an agile, capabilities-driven business.

Pharmachem是该公司的原始名称，从1972年成立到2017年一直使用。随着Pharmachem再次成为一家独立公司，该团队很高兴能够利用其传统名称，同时添加“创新”，以反映其作为一家敏捷、能力驱动的企业的发展道路。

About Pharmachem Innovations

关于Pharmachem Innovations

Pharmachem Innovations is a leader in the development and production of nutraceuticals ingredients, providing both proprietary nutrition ingredients and custom formulation services to nutritional product companies.

Pharmachem Innovations是营养品成分开发和生产的领导者，为营养产品公司提供专有营养成分和定制配方服务。

About Turnspire Capital Partners

关于Turnspire Capital Partners

Turnspire Capital Partners invests in high-quality businesses that have reached strategic, financial or operational inflection points and stand to benefit from our hands-on, operationally focused approach. Turnspire’s investment philosophy is predicated on creating value through operational improvements rather than through financial leverage.

Turnspire Capital Partners投资于已达到战略、财务或运营拐点的高质量业务，并将受益于我们以实际操作为重点的方法。Turnspire的投资理念是通过运营改进而不是通过财务杠杆创造价值。

Turnspire strives to make each of its portfolio companies best-in-class in their respective industry niche, and then to grow the businesses through organic initiatives or strategic acquisitions. For additional information, please visit www.turnspirecap.com..

Turnspire致力于使其投资组合中的每一家公司在各自的行业利基中成为一流的公司，然后通过有机举措或战略收购来发展业务。有关更多信息，请访问www.turnspirecap.com。。